Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%

Zacks Bull and Bear of the Day Highlights: United Therapeutics, Intel, CBS, News Corp and Comcast

August 01, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

For Immediate Release

Chicago, IL – August 1, 2012 – Zacks Equity Research highlights United Therapeutics Corp. (UTHR - Analyst Report) as the Bull of the Day and Intel Corp. (INTC - Analyst Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on CBS Corporation (CBS - Analyst Report), News Corporation (NWSA - Analyst Report) and Comcast Corporation (CMCSA - Analyst Report).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2678.

Here is a synopsis of all five stocks:

Bull of the Day:

United Therapeutics Corp.'s (UTHR - Analyst Report) second quarter earnings of $1.43 per share were well above the year-ago earnings of $1.19 and the Zacks Consensus Estimate of $1.12. Higher revenues led to the improvement in earnings. The company maintained its guidance for 2012.

We believe the company is well-positioned to gain share in the pulmonary arterial hypertension (PAH) market. Lead product Remodulin continues to look very strong in both the intravenous (IV) and subcutaneous (SC) forms. With the approval of Adcirca and Tyvaso, the company has a varied range of therapies available for the treatment of PAH.

We believe the company's PAH product portfolio will drive strong top-and bottom-line growth. We maintain our Outperform recommendation on United Therapeutics, which carries a Zacks #2 Rank (short-term Buy rating).

Bear of the Day:

Intel Corp. (INTC - Analyst Report) beat the Zacks Consensus by $0.04 in the second quarter, driven by strength in server and software businesses and supported by a moderate PC business. Guidance disappointed, however, due to lower builds at distributors.

Intel also remains a laggard in the mobile segment, and although its situation could improve by virtue of its Ultrabook and agreement with Google, Intel has yet to prove itself here. In the meantime, competition from ARM-based devices continues to intensify.

Therefore, given the PC market weakness and the fact that mobile devices will continue to eat into its client business, we downgrade Intel shares from Neutral to Underperform. We are setting a target price of $24.00, which is 10.0X our earnings expectations for 2012.

Latest Posts on the Zacks Analyst Blog:

Earnings Preview: CBS Corp.

CBS Corporation (CBS - Analyst Report), one of the leading media company in United States and worldwide, is expected to release its second-quarter 2012 financial results on Thursday, August 2, 2012, after the market closes.

The Zacks Consensus Estimate for second quarter 2012 stands at 58 cents, flat year over year. The estimate lies between a low of 54 cents and a high of 64 cents. Revenue, as per the Zacks Consensus Estimate, is pegged at $3,543 million.

First Quarter Highlights

CBS Corporation posted better-than-expected first quarter 2012 results. Quarterly earnings of 54 cents per share were way ahead of the Zacks Consensus Estimate of 44 cents and surged 86% from 29 cents earned in the year-ago quarter.

Revenues jumped 12% year over year to $3,924 million. The growth was due to a 39% rise in content licensing and distribution revenues to $1,017 million along with a 5% increase in advertising revenues to $2,398 million. Moreover, affiliate and subscription fees rose 7% to $455 million. Total revenue also exceeded the Zacks Consensus Estimate of $3,780 million.

Agreement of Estimate Revisions

For the second-quarter of 2012, one and two estimates went up (out of 22) in the last 7 and 30 days, respectively, whereas two estimates were trimmed in the last 30 days. For fiscal 2012, out of 25 estimates, two and seven estimates were revised upwards over the last 7 and 30 days, respectively, and two estimates went down in the last 30 days.

Magnitude of Estimate Revisions

Due to the lack of near-term catalysts impacting the estimates directly or indirectly, the estimates remained unchanged at 58 cents over the last 7 and 30 days for the to-be-reported quarter, whereas for fiscal 2012, the estimates went up by a penny over the last 30 days.

Positive Earnings Surprise History

CBS Corporation has been performing well, reflected by the better-than-expected results over the last four quarters. With respect to earnings surprise, CBS Corp has outperformed the Zacks Consensus Estimate with an average of 17.0% over the last four quarters. Looking at the company’s past performance, we expect CBS to top the estimates in the coming quarters as well.

Conclusion

CBS, which competes with News Corporation (NWSA - Analyst Report) and Comcast Corporation (CMCSA - Analyst Report), has been actively managing its cash flows by generating healthy free cash, making prudent capital investments and enhancing shareholders’ return.

The company generated free cash flow of $607 million, incurred capital expenditures of $39 million, repurchased shares worth of $269 billion in the first quarter and ended with cash and cash equivalents of $794 million.

The company’s decision to increase its share repurchases authorization and dividend clearly suggests the ability to generate liquidity and its potential to improve in the long run.

CBS remains well positioned to drive revenue growth in the coming quarters through its strategic initiatives and operating efficiencies. Management remains optimistic and expects growth momentum to continue in fiscal 2012 based on reverse compensation from affiliates, strong demand of its content and online video streaming, retransmission consent, and political advertising.

Based on better-than-expected results and ability to generate strong free cash flow, CBS Corporation carries Zacks #2 Rank, implying a short-term Buy rating. We also maintain our long-term Outperform recommendation on the stock.

Get the full analysis of all these stocks by going to http://at.zacks.com/?id=2649.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=7158.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment

Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4582.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.